digiM Joins DDIC to Support Drug Delivery Research

We are thrilled to announce that digiM is now as a consortium member of the INVITE Drug Delivery Innovation Center (DDIC). This partnership marks an important milestone in our journey, where we will support critical research initiatives in the development of novel drug delivery technologies and manufacturing.

The DDIC, established in 2017 by industry giants such as Bayer AG, LB Bohle GmbH, Merck KGaA, and UCB S.A, alongside academic powerhouses TU Dortmund and HHU Düsseldorf, with leadership from INVITE GmbH, aims to foster international, multidisciplinary collaborations in drug delivery research. By joining this group, digiM is poised to contribute significantly to the consortium’s goals, promoting pharmaceutical science through close collaboration with academia and the pharmaceutical industry. We are excited about the opportunities this partnership will bring to digiM and the broader pharmaceutical community. Together with the DDIC, we are set to embark on a journey of discovery and innovation, aiming to redefine the boundaries of drug delivery and manufacturing.